US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class III · Low risk Terminated

Phytonadione Tablets 5mg

Reason Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Bausch Health Companies, Inc. NDC 68682-170-30 D-0244-2021
Class III · Low risk Terminated

Mephyton

Reason Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Bausch Health Companies, Inc. NDC 0187-1704-05 D-0243-2021
Class II · Moderate risk Terminated

Nitrofurantoin Capsules USP

Reason Failed Dissolution Specifications

American Health Packaging D-0232-2021
Class II · Moderate risk Terminated

Sulfur Ointment 10%

Reason Labeling: Label Mix-Up. THe English label with Drug Facts panel for Camphor was incorrectly placed on product.

DLC Laboratories, Inc D-0257-2021
Class II · Moderate risk Terminated

Chlorhexidine Gluconate Oral Rinse USP 0.12%

Reason cGMP deviations: The firm was notified of the manufacturer's expanded recall.

Precision Dose Inc. NDC 68094-028-61 D-0228-2021
Class II · Moderate risk Terminated

Acetaminophen Injection 1

Reason Discoloration and failed pH specifications

AuroMedics Pharma LLC NDC 55150-307-01 D-0248-2021
Class II · Moderate risk Terminated

Levetiracetam Oral Solution

Reason Defective container: Customer complaints for oral solution leaking from bottles.

Akorn, Inc. NDC 50383-241-16 D-0221-2021
Class I · High risk Terminated

Ketorolac Tromethamine Injection

Reason Presence of Particulate Matter - found in reserve sample vials at the firm.

Fresenius Kabi USA, LLC NDC 63323-162-00 D-0245-2021
Class II · Moderate risk Terminated

IMC Wash-Free Hand Sanitizer

Reason CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.

Shane Erickson Inc D-0241-2021
Class II · Moderate risk Terminated

IMC Wash-Free Hand Sanitizer

Reason CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.

Shane Erickson Inc D-0240-2021
Class II · Moderate risk Terminated

IMC Wash-Free Hand Sanitizer

Reason CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.

Shane Erickson Inc D-0239-2021
Class III · Low risk Terminated

Oxycodone Hydrochloride Oral Solution

Reason Presence of Foreign Substance: Particulate matter was found in multiple lots of product.

Genus Lifesciences Inc. NDC 64950-354-05 D-0231-2021
Class III · Low risk Terminated

Epinephrine/Lidocaine HCl

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Edge Pharma, LLC NDC 05446-0863-01 D-0307-2021
Class II · Moderate risk Terminated

Zerbaxa

Reason Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.

Merck Sharp & Dohme NDC 67919-030-01 D-0176-2021
Class III · Low risk Terminated

Benzhydrocodone and Acetaminophen Tablets

Reason Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

KVK-Tech, Inc. NDC 10702-344-01 D-0224-2021
Class II · Moderate risk Terminated

fentaNYL 100 mcg/2mL Injection for IV or IM Use

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0214-2021
Class II · Moderate risk Terminated

SUCcinylcholine Chloride 100 mg/5mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0212-2021
Class II · Moderate risk Terminated

Rocuronium Br 50 mg/5mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0211-2021